Basilea Pharmaceutica AG (SWX: BSLN)
45.40
-0.15 (-0.33%)
Sep 4, 2024, 5:30 PM CET
Basilea Pharmaceutica AG Balance Sheet
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Cash & Equivalents | 14.28 | 14.21 | 24.07 | 28.62 | 28.39 | 20.8 | Upgrade
|
Cash & Short-Term Investments | 14.28 | 14.21 | 24.07 | 28.62 | 28.39 | 20.8 | Upgrade
|
Cash Growth | -15.33% | -40.96% | -15.92% | 0.83% | 36.47% | 13.46% | Upgrade
|
Accounts Receivable | 9.16 | 6.41 | 2.82 | 1.69 | 1.04 | 0.76 | Upgrade
|
Other Receivables | 1.83 | 1.21 | 0.8 | 0.36 | 0.37 | 0.32 | Upgrade
|
Receivables | 10.98 | 7.62 | 3.62 | 2.05 | 1.4 | 1.08 | Upgrade
|
Inventory | 6.85 | 4.86 | 3.17 | 1.76 | 1.46 | 0.95 | Upgrade
|
Prepaid Expenses | 1.13 | 0.51 | 0.54 | 0.47 | 0.55 | 0.46 | Upgrade
|
Other Current Assets | - | - | - | - | 2.17 | - | Upgrade
|
Total Current Assets | 33.24 | 27.19 | 31.39 | 32.89 | 33.97 | 23.29 | Upgrade
|
Property, Plant & Equipment | 2.94 | 2.64 | 2.32 | 2.45 | 2.59 | 2.78 | Upgrade
|
Goodwill | 24.74 | 24.47 | 29.31 | 33.39 | 33.85 | 33.86 | Upgrade
|
Other Intangible Assets | 16.17 | 16.51 | 19.41 | 22.61 | 23.67 | 27.92 | Upgrade
|
Long-Term Deferred Tax Assets | 0.1 | 0.64 | 0.5 | - | 0.3 | - | Upgrade
|
Other Long-Term Assets | 0.11 | 0.01 | - | - | - | - | Upgrade
|
Total Assets | 77.3 | 71.46 | 82.95 | 91.34 | 94.36 | 87.85 | Upgrade
|
Accounts Payable | 2.83 | 1.3 | 1.3 | 0.85 | 0.94 | 1.06 | Upgrade
|
Accrued Expenses | 8.73 | 7.87 | 4.96 | 3.6 | 2.59 | 2.29 | Upgrade
|
Current Portion of Leases | 0.61 | 0.65 | 0.48 | 0.38 | 0.35 | 0.29 | Upgrade
|
Other Current Liabilities | - | 3.38 | 5.84 | 6.46 | - | - | Upgrade
|
Total Current Liabilities | 12.17 | 13.19 | 12.59 | 11.29 | 3.88 | 3.64 | Upgrade
|
Long-Term Leases | 1.36 | 1.57 | 1.5 | 1.83 | 2.06 | 2.14 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | 0.89 | 3.24 | 3.49 | Upgrade
|
Total Liabilities | 17.13 | 14.75 | 14.09 | 14.36 | 9.76 | 10 | Upgrade
|
Common Stock | 3.71 | 3.68 | 3.66 | 3.28 | 32.81 | 22.47 | Upgrade
|
Additional Paid-In Capital | 74.11 | 73.32 | 160.16 | 154.59 | 125.06 | 118.16 | Upgrade
|
Retained Earnings | -42.28 | -42.15 | -115.83 | -101.59 | -94.27 | -81.9 | Upgrade
|
Treasury Stock | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | Upgrade
|
Comprensive Income & Other | 24.65 | 21.89 | 20.9 | 20.71 | 21.02 | 19.15 | Upgrade
|
Shareholders' Equity | 60.18 | 56.71 | 68.86 | 76.98 | 84.6 | 77.86 | Upgrade
|
Total Liabilities & Equity | 77.3 | 71.46 | 82.95 | 91.34 | 94.36 | 87.85 | Upgrade
|
Total Debt | 1.96 | 2.21 | 1.98 | 2.21 | 2.41 | 2.44 | Upgrade
|
Net Cash (Debt) | 12.31 | 12 | 22.09 | 26.41 | 25.98 | 18.37 | Upgrade
|
Net Cash Growth | -12.01% | -45.67% | -16.38% | 1.66% | 41.45% | 0.17% | Upgrade
|
Net Cash Per Share | 0.42 | 0.33 | 0.65 | 0.81 | 1.07 | 1.16 | Upgrade
|
Filing Date Shares Outstanding | 21.1 | 36.77 | 36.54 | 32.79 | 32.79 | 22.45 | Upgrade
|
Total Common Shares Outstanding | 21.1 | 36.77 | 36.54 | 32.79 | 32.79 | 22.45 | Upgrade
|
Working Capital | 21.08 | 14.01 | 18.8 | 21.6 | 30.09 | 19.65 | Upgrade
|
Book Value Per Share | 2.85 | 1.54 | 1.88 | 2.35 | 2.58 | 3.47 | Upgrade
|
Tangible Book Value | 19.27 | 15.74 | 20.13 | 20.98 | 27.09 | 16.08 | Upgrade
|
Tangible Book Value Per Share | 0.91 | 0.43 | 0.55 | 0.64 | 0.83 | 0.72 | Upgrade
|
Machinery | 2.38 | 1.75 | 1.51 | 1.18 | 0.94 | 0.88 | Upgrade
|
Leasehold Improvements | 0.07 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.